Literature DB >> 31097340

Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study.

Sandro Barni1, Luca Livraghi2, Adriano Gravina3, Francesca Martella4, Loretta D'Onofrio5, Maria Morritti6, Andrea Michelotti7, Patrizia Vici8, Lucia Mentuccia9, Luca Porcu10, Michele Orditura11, Fabio Puglisi12.   

Abstract

Entities:  

Keywords:  Aged; Eribulin; Metastatic breast cancer; Safety

Year:  2019        PMID: 31097340     DOI: 10.1016/j.jgo.2019.05.003

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


× No keyword cloud information.
  1 in total

Review 1.  Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects.

Authors:  Hikmat Abdel-Razeq; Fawzi Abu Rous; Fawzi Abuhijla; Nayef Abdel-Razeq; Sarah Edaily
Journal:  Clin Interv Aging       Date:  2022-09-28       Impact factor: 3.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.